We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
352 hedge funds and large institutions have $10.7B invested in Madrigal Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 107 increasing their positions, 107 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
135% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 37
50% more capital invested
Capital invested by funds: $7.13B → $10.7B (+$3.6B)
27% more call options, than puts
Call options by funds: $326M | Put options by funds: $258M
17% more funds holding in top 10
Funds holding in top 10: 12 → 14 (+2)
15% more funds holding
Funds holding: 305 → 352 (+47)
0% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 107
0.74% less ownership
Funds ownership: 106.08% → 105.34% (-0.74%)
Holders
352
Holders Change
+47
Holders Change %
+15.41%
% of All Funds
4.62%
Holding in Top 10
14
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+16.67%
% of All Funds
0.18%
New
87
Increased
107
Reduced
107
Closed
37
Calls
$326M
Puts
$258M
Net Calls
+$68.8M
Net Calls Change
-$69.9M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$148M |
| 2 |
Goldman Sachs
New York
|
+$73.2M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$61.8M |
| 4 |
BlackRock
New York
|
+$45.1M |
| 5 |
Alkeon Capital Management
New York
|
+$44.8M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$130M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$108M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$107M |
| 4 |
PC
Paulson & Co
New York
|
-$67.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$59.3M |
